Viewing Study NCT03712202


Ignite Creation Date: 2025-12-25 @ 3:43 AM
Ignite Modification Date: 2025-12-26 @ 2:29 AM
Study NCT ID: NCT03712202
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-06
First Post: 2018-08-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module